Consolidated Statements of Comprehensive Loss - USD ($)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenues
Total revenues	$ 0	$ 0
Operating expenses:
Research and development	1,554,603	2,009,323
General and administrative	3,032,138	2,769,161
Total operating expenses	4,586,741	4,778,484
Loss from operations	(4,586,741)	(4,778,484)
Interest (expense) income	(2,007,687)	3,926
Loss before income tax benefit	(6,594,428)	(4,774,558)
Provision for income tax benefit	335,832	614,362
Net loss	(6,258,596)	(4,160,196)
Other comprehensive income
Foreign currency translation adjustment, net of tax	472,559	2,896
Comprehensive loss	$ (5,786,037)	$ (4,157,300)
Net loss per share, basic and diluted	$ (0.28)	$ (0.20)
Weighted average number of common shares outstanding	22,283,377	20,806,307